ACH-806, an NS4A Antagonist, Inhibits Hepatitis C Virus Replication by Altering the Composition of Viral Replication Complexes

Treatment of hepatitis C patients with direct-acting antiviral drugs involves the combination of multiple small-molecule inhibitors of distinctive mechanisms of action. ACH-806 (or GS-9132) is a novel, small-molecule inhibitor specific for hepatitis C virus (HCV). It inhibits viral RNA replication i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yang, Wengang, Sun, Yongnian, Hou, Xiaohong, Zhao, Yongsen, Fabrycki, Joanne, Chen, Dawei, Wang, Xiangzhu, Agarwal, Atul, Phadke, Avinash, Deshpande, Milind, Huang, Mingjun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3697357/
https://ncbi.nlm.nih.gov/pubmed/23629709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02630-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak